Printer Friendly

Swedish life science company Biolin AB to spin off dental implants business Ospol.

NORDIC BUSINESS REPORT-9 September 2008-Swedish life science company Biolin AB to spin off dental implants business Ospol(C)1994-2008 M2 COMMUNICATIONS LTD

Swedish life science company Biolin AB (OMX Stockholm: BLIN) announced on Tuesday (9 September) that it has decided to spin off its dental implant systems subsidiary Ospol and to focus on its core business of developing analytical instruments.

Biolin said that its plan is to carry out the spin-off and a separate listing on the OMX First North market for Ospol during the autumn.

In connection with the spin-off, Ospol will also carry out a new shares issue, which is expected to raise SEK10-30m. The funding will carry the company through the next two or three years.

Biolin, headquartered Sweden, develops and markets analytical instruments for scientists and clinicians in nanotechnology and biotechnology. The company reported sales of SEK79.7m in 2007.

One British pound (GBP) is worth approximately 11.72 Swedish kronor (SEK).

((Comments on this story may be sent to

COPYRIGHT 2008 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nordic Business Report
Date:Sep 9, 2008
Previous Article:Outotec Oyj wins order for iron ore sinter plant in India.
Next Article:Swedish electrical products trading company Malmbergs Elektriska AB opens office in Hong Kong.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters